{"id":"https://openalex.org/W2172209374","doi":"https://doi.org/10.1158/1078-0432.ccr-06-0109","title":"Preclinical Evaluation of Antiangiogenic Thrombospondin-1 Peptide Mimetics, ABT-526 and ABT-510, in Companion Dogs with Naturally Occurring Cancers","display_name":"Preclinical Evaluation of Antiangiogenic Thrombospondin-1 Peptide Mimetics, ABT-526 and ABT-510, in Companion Dogs with Naturally Occurring Cancers","publication_year":2006,"publication_date":"2006-12-15","ids":{"openalex":"https://openalex.org/W2172209374","doi":"https://doi.org/10.1158/1078-0432.ccr-06-0109","mag":"2172209374","pmid":"https://pubmed.ncbi.nlm.nih.gov/17189418"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-06-0109","doi":"https://doi.org/10.1158/1078-0432.ccr-06-0109","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-06-0109","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110307139","display_name":"Anthony W. Rusk","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anthony Rusk","raw_affiliation_strings":["1Animal Clinical Investigation, LLC, Columbia, Maryland and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Animal Clinical Investigation, LLC, Columbia, Maryland and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087951266","display_name":"Evelyn Mary McKeegan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evelyn McKeegan","raw_affiliation_strings":["2Abbott Laboratories, Abbott Park, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Abbott Laboratories, Abbott Park, Illinois","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071851392","display_name":"Fortuna Haviv","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fortuna Haviv","raw_affiliation_strings":["2Abbott Laboratories, Abbott Park, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Abbott Laboratories, Abbott Park, Illinois","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048230431","display_name":"Sandra M. Majest","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandra Majest","raw_affiliation_strings":["2Abbott Laboratories, Abbott Park, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Abbott Laboratories, Abbott Park, Illinois","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000025451","display_name":"Jack Henkin","orcid":"https://orcid.org/0000-0003-4226-3688","observed_orcids":["https://orcid.org/0000-0003-4226-3688"]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jack Henkin","raw_affiliation_strings":["2Abbott Laboratories, Abbott Park, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Abbott Laboratories, Abbott Park, Illinois","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112077722","display_name":"Chand Khanna","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chand Khanna","raw_affiliation_strings":["1Animal Clinical Investigation, LLC, Columbia, Maryland and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Animal Clinical Investigation, LLC, Columbia, Maryland and","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.0729,"has_fulltext":false,"cited_by_count":78,"citation_normalized_percentile":{"value":0.97086306,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"12","issue":"24","first_page":"7444","last_page":"7455"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11149","display_name":"Veterinary Oncology Research","score":0.8349999785423279,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11149","display_name":"Veterinary Oncology Research","score":0.8349999785423279,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.16349999606609344,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11214","display_name":"Human-Animal Interaction Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thrombospondin-1","display_name":"thrombospondin-1","score":0.8899999856948853},{"id":"https://openalex.org/keywords/peptidomimetics","display_name":"peptidomimetics","score":0.8679999709129333},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.9610000252723694},{"id":"https://openalex.org/keywords/canine-cancer","display_name":"canine cancer","score":0.7450000047683716},{"id":"https://openalex.org/keywords/pet-dogs","display_name":"pet dogs","score":0.7390000224113464},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.652999997138977},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8050000071525574},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7860000133514404},{"id":"https://openalex.org/keywords/circulating-endothelial-cells","display_name":"circulating endothelial cells","score":0.9190000295639038},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8650000095367432},{"id":"https://openalex.org/keywords/soft-tissue-sarcoma","display_name":"soft tissue sarcoma","score":0.8569999933242798},{"id":"https://openalex.org/keywords/cutaneous-t-cell-lymphoma","display_name":"cutaneous T-cell lymphoma","score":0.9520000219345093},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.953000009059906},{"id":"https://openalex.org/keywords/head-and-neck-cancer","display_name":"head and neck cancer","score":0.925000011920929},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7160000205039978}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7447835803031921},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6186591386795044},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.615967333316803},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5849319100379944},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5358024835586548},{"id":"https://openalex.org/C99194444","wikidata":"https://www.wikidata.org/wiki/Q14906367","display_name":"Thrombospondin 1","level":3,"score":0.5103959441184998},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.508817732334137},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.45177358388900757},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.40327584743499756},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3688638210296631},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36738553643226624},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3450317978858948},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16945943236351013},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002465","descriptor_name":"Cell Movement","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019700","descriptor_name":"Thrombospondin 1","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019700","descriptor_name":"Thrombospondin 1","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D019700","descriptor_name":"Thrombospondin 1","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019700","descriptor_name":"Thrombospondin 1","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019700","descriptor_name":"Thrombospondin 1","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D042783","descriptor_name":"Endothelial Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-06-0109","doi":"https://doi.org/10.1158/1078-0432.ccr-06-0109","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-06-0109","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:17189418","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17189418","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W186058546","https://openalex.org/W1646532278","https://openalex.org/W1966928897","https://openalex.org/W2007799501","https://openalex.org/W2008677826","https://openalex.org/W2012934299","https://openalex.org/W2019347837","https://openalex.org/W2023659339","https://openalex.org/W2029883816","https://openalex.org/W2033791403","https://openalex.org/W2037136309","https://openalex.org/W2044743642","https://openalex.org/W2050299423","https://openalex.org/W2050806244","https://openalex.org/W2054627635","https://openalex.org/W2059322719","https://openalex.org/W2070572487","https://openalex.org/W2075586472","https://openalex.org/W2088929622","https://openalex.org/W2117413404","https://openalex.org/W2123422145","https://openalex.org/W2133097576","https://openalex.org/W2139711019","https://openalex.org/W2150048971","https://openalex.org/W2158965678","https://openalex.org/W2166753481","https://openalex.org/W2344589255","https://openalex.org/W2400262641","https://openalex.org/W4250732702","https://openalex.org/W6634782787"],"related_works":["https://openalex.org/W1967138087","https://openalex.org/W2242175185","https://openalex.org/W2143104570","https://openalex.org/W2077265259","https://openalex.org/W2476490210","https://openalex.org/W2023659339","https://openalex.org/W3016743029","https://openalex.org/W2050299423","https://openalex.org/W601283949","https://openalex.org/W2324438893"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1,103],"angiogenic":[2],"phenotype":[3],"of":[4,22,43,84,157,193,202,228,247],"malignant":[5,71,237],"cancers":[6,53],"has":[7],"been":[8],"established":[9],"as":[10,251],"a":[11,199],"target":[12],"for":[13,106,167],"cancer":[14],"therapy.":[15],"ABT-526":[16,65,109,229],"and":[17,29,32,81,93,108,112,170,180,189,226,230],"ABT-510,":[18],"two":[19],"peptide":[20,133],"mimetics":[21],"thrombospondin-1":[23],"(TSP-1),":[24],"block":[25],"angiogenesis":[26],"in":[27,30,36,48,66,86,124,139,173,198,216,232],"vitro":[28],"vivo":[31],"slow":[33],"tumor":[34,140],"growth":[35],"mice.":[37],"To":[38],"guide":[39],"the":[40,160,224,245],"clinical":[41],"development":[42,246],"these":[44],"drugs,":[45],"translational":[46],"studies":[47],"dogs":[49,68,95,126,131,203,233],"with":[50,69,214,234],"naturally":[51,235],"occurring":[52,236],"were":[54,96,122,152],"initiated.":[55],"EXPERIMENTAL":[56],"DESIGN:":[57],"A":[58],"prospective":[59],"open-label":[60,101],"trial":[61,243],"using":[62],"ABT-510":[63,107,231],"or":[64,145],"pet":[67],"measurable":[70],"spontaneously":[72],"arising":[73],"tumors.":[74],"Endpoints":[75],"included":[76],"safety,":[77],"pharmacokinetics,":[78],"antitumor":[79],"activity,":[80],"preliminary":[82],"assessment":[83],"changes":[85],"circulating":[87,194,217],"endothelial":[88,195,218],"cell":[89,196],"populations.":[90],"RESULTS:":[91],"Two-hundred":[92],"forty-two":[94],"sequentially":[97],"entered":[98],"to":[99,159,208],"this":[100,241],"trial.":[102],"elimination":[104],"half-life":[105],"was":[110,165,171],"0.7":[111],"0.8":[113],"h,":[114],"respectively":[115],"(range,":[116],"0.5-1":[117],"h).":[118],"No":[119],"dose-limiting":[120],"toxicities":[121],"seen":[123,153,172],"any":[125],"(N":[127],"=":[128,143],"242).":[129],"Forty-two":[130],"receiving":[132],"had":[134],"objective":[135,150],"responses":[136,151],"(>50%":[137],"reduction":[138],"size;":[141],"n":[142],"6)":[144],"significant":[146],"disease":[147],"stabilization.":[148],"Most":[149],"after":[154],"60":[155],"days":[156],"exposure":[158,207],"TSP-1":[161,209,248],"peptide.":[162],"Antitumor":[163],"activity":[164,227],"similar":[166],"both":[168],"peptides":[169,210,250],"several":[174],"histologies,":[175],"including":[176],"mammary":[177],"carcinoma,":[178,182],"head":[179],"neck":[181],"soft":[183],"tissue":[184],"sarcoma,":[185],"cutaneous":[186],"T-cell":[187],"lymphoma,":[188],"non-Hodgkin's":[190],"lymphoma.":[191],"Assessment":[192],"populations":[197],"small":[200],"subset":[201],"suggested":[204],"that":[205],"effective":[206],"may":[211],"be":[212],"associated":[213],"reductions":[215],"cells.":[219],"CONCLUSIONS:":[220],"These":[221],"results":[222],"support":[223,244],"safety":[225],"cancers.":[238],"Data":[239],"from":[240],"preclinical":[242],"mimetic":[249],"anticancer":[252],"agents.":[253]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":7}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}